Expert Insights
Latest Release
How to Choose a Biologics CDMO: The 4 Selection Criteria According to Ralf Otto, CDMO Operations Expert and Rezon Bio’s COO
Rezon Bio news
Expert Insights
Expert Insights
What about USP <665> today? Insights from MS&T Customer Projects Team
Aug 25, 2026
Article
“We Are Not a Newcomer”: Rezon Bio’s New COO on Its Biologics CDMO Track Record
Aug 5, 2026
Presentation
Enabling affordable biologics through advanced process optimization: A manufacturing case study
Jul 24, 2026
White Paper
Building Late-Stage Efficiency Into Biologics Development
Jul 15, 2026
Podcast
Podcast with Adriana Kiędzierska-Mencfeld
Jul 13, 2026
Expert Insights
FAQ
Q: Does Rezon Bio offer integrated analytical development for biosimilar comparability studies?
Jul 2, 2026
Press Release
Rezon Bio Appoints Dr. Hubert Scholze as Chief Business Officer to Accelerate Global Commercial Expansion
Jul 1, 2026
FAQ
Q: Can a single CDMO manage both clinical and commercial biologics supply?
Jun 26, 2026
Article
Dual source manufacturing strategy: One program. Two regions. One integrated team.
Jun 24, 2026No posts found.
Loading…